Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 HKD | -0.44% | -11.05% | -34.54% |
05-16 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
05-14 | Innocare Pharma Posts Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.54% | 1.14B | |
+9.92% | 118B | |
+9.90% | 106B | |
-11.06% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.67% | 15.97B | |
+6.92% | 14.03B | |
+16.32% | 11.67B |
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- Innocare Pharma Posts Q1 Loss